在惊恐障碍中用氯氮平增强帕罗西汀的疗效。 - Suppr

Suppr

超能文献

Augmentation of paroxetine with clocapramine in panic disorder.

作者信息

Saito Masanori, Miyaoka Hitoshi

出版信息

Psychiatry Clin Neurosci. 2007 Aug;61(4):449. doi: 10.1111/j.1440-1819.2007.01690.x.

DOI:10.1111/j.1440-1819.2007.01690.x

PMID:17610675

Abstract

摘要

相似文献

Augmentation of paroxetine with clocapramine in panic disorder.

Psychiatry Clin Neurosci. 2007 Aug;61(4):449. doi: 10.1111/j.1440-1819.2007.01690.x.

Exacerbation of extrapyramidal symptoms with paroxetine.

Aust N Z J Psychiatry. 1995 Sep;29(3):521-2.

[Clinical picture and treatment of panic disorder accompanied with generalized anxiety].

Voen Med Zh. 2007 Jan;328(1):38-43.

Treatment of panic disorder: focus on paroxetine.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:53-63.

Lower gastrointestinal bleeding and paroxetine use: two case reports.

Psychosomatics. 2012 Mar-Apr;53(2):184-7. doi: 10.1016/j.psym.2011.09.002.

Efficacy studies of paroxetine in panic disorder.

Psychopharmacol Bull. 1998;34(2):175-82.

Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.

Biol Psychiatry. 1997 Jul 15;42(2):144-6. doi: 10.1016/S0006-3223(97)00248-5.

Olanzapine in the treatment of resistant depression.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):108-9. doi: 10.1111/j.1440-1614.2005.01520.x.

[Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].

Ter Arkh. 2000;72(10):16-23.

Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):564-6. doi: 10.1016/j.pnpbp.2006.10.014. Epub 2006 Dec 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Augmentation of paroxetine with clocapramine in panic disorder.

作者信息

Saito Masanori, Miyaoka Hitoshi

出版信息

Psychiatry Clin Neurosci. 2007 Aug;61(4):449. doi: 10.1111/j.1440-1819.2007.01690.x.

DOI:10.1111/j.1440-1819.2007.01690.x

PMID:17610675

Abstract

摘要

相似文献

Augmentation of paroxetine with clocapramine in panic disorder.

Psychiatry Clin Neurosci. 2007 Aug;61(4):449. doi: 10.1111/j.1440-1819.2007.01690.x.

Exacerbation of extrapyramidal symptoms with paroxetine.

Aust N Z J Psychiatry. 1995 Sep;29(3):521-2.

[Clinical picture and treatment of panic disorder accompanied with generalized anxiety].

Voen Med Zh. 2007 Jan;328(1):38-43.

Treatment of panic disorder: focus on paroxetine.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:53-63.

Lower gastrointestinal bleeding and paroxetine use: two case reports.

Psychosomatics. 2012 Mar-Apr;53(2):184-7. doi: 10.1016/j.psym.2011.09.002.

Efficacy studies of paroxetine in panic disorder.

Psychopharmacol Bull. 1998;34(2):175-82.

Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.

Biol Psychiatry. 1997 Jul 15;42(2):144-6. doi: 10.1016/S0006-3223(97)00248-5.

Olanzapine in the treatment of resistant depression.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):108-9. doi: 10.1111/j.1440-1614.2005.01520.x.

[Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].

Ter Arkh. 2000;72(10):16-23.

Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):564-6. doi: 10.1016/j.pnpbp.2006.10.014. Epub 2006 Dec 12.